Usefulness of docking and molecular dynamics in selecting tumor neoantigens to design personalized cancer vaccines: a proof of concept.
D. Amaya-Ramirez, L. C. Martinez-Enriquez, C. Parra-Lopez
This paper evaluates using molecular docking and dynamics to identify immunogenic tumor neoantigens by analyzing their stability with HLA-A2, showing agreement with in vitro results and highlighting key peptide positions.
bioRxiv · Dec 22, 2022 · PreprintImmunology